VR Logo

Biophytis SA (BPTS) download report


Healthcare | Biotechnology & Pharma Research

Biophytis SA (BPTS) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases.

IPO Date: 10-Feb-2021

Chairman & CEO: Mr. Stanislas Veillet Ph.D.

Chief Financial Officer: Mr. Philippe J. Rousseau

Listing: NASDAQ: BPTS

Country: France

Headquarters: Paris,

Website: https://www.biophytis.com

Key Facts

Market cap: $17.97 Mln

Revenue (TTM): €0.00 Mln

Earnings (TTM): €-31.25 Mln

Cash: €25.16 Mln

Total Debt: €15.38 Mln

Insider's Holding: 0.00%

Liquidity: Low

52 Week range: $0.94 - 10.69

Shares outstanding: 14,754,100

9 Years Aggregate:

  • CFO: €-81.02 Mln
  • EBITDA: €-94.63 Mln
  • Net Profit: €-103.96 Mln

Stock Performance

Time Period Biophytis SA (BPTS) S&P BSE Sensex S&P Small-Cap 600
YTD-77.90-8.99-19.87
1 month-7.09-3.40-10.07
3 months-56.05-8.50-17.25
1 Year-88.780.89-18.01
3 Years--10.415.62
5 Years--11.435.60
10 Years--11.779.69
As on 30-Jun-2022